2026 NPPES data Transplant Hepatology Physician NPI 1043404593 MD
Verify on CMS →

MING LIN, MD

Transplant Hepatology Physician in BURLINGTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
671
Medicare Part D claims · 159 beneficiaries · Transplant Hepatology Physician avg: 536
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$270.14
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MING LIN, MD filed 671 Medicare Part D claims in 2023 as a Transplant Hepatology Physician in BURLINGTON, Massachusetts, prescribing 85% generic.

671
Part D claims, 2023
85%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MING LIN, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

671 Top 31% higher than 69% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MING LIN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MING LIN, MD?

Quality data not reported

NPI registry status

Active

Issued 08/28/2007

NPI 1043404593

Primary specialty

Transplant Hepatology Physician

Rare

131 US NPIs in this specialty

Medicare Part D claims

671 25% vs specialty avg

2023 prescription claims

Specialty avg: 536

Specialty distribution in Massachusetts

How Transplant Hepatology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Transplant Hepatology Physician share within Massachusetts

1. Transplant Hepatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Transplant Hepatology Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Transplant Hepatology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Transplant Hepatology Physician ABMS/AOA estimate

Est. board-certified rate (Transplant Hepatology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Transplant Hepatology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MING LIN, MD appears in the CMS NPPES registry as a Transplant Hepatology Physician provider holding MD credentials at LAHEY HOSPITAL & MEDICAL CENTER, BURLINGTON, MA, 01805, with a listed phone of (781) 744-2500. NPI 1043404593 was issued on 08/28/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 671 prescription claims written by this provider, covering 159 Medicare beneficiaries and totaling roughly $346K in drug spend, split 15% brand-name and 85% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Transplant Hepatology Physician is a narrow specialty nationwide, with 131 enrolled providers across 36 states and an average of 536 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

LAHEY HOSPITAL & MEDICAL CENTER
BURLINGTON, MA 01805

Provider Details

NPI 1043404593
Specialty Transplant Hepatology Physician
Credentials MD
Gender Female
NPI Issued 08/28/2007

Hospital and facility affiliations

Facilities where MING LIN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

LAHEY CLINIC INC
BURLINGTON, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MING LIN, MD. Source: openpaymentsdata.cms.gov.

Total received

$270

Largest payer

Madrigal Pharmaceuticals

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to MING LIN, MD. To verify MING LIN, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MING LIN, MD — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 671 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

671
Total Claims
$346K
Total Drug Cost
159
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,348
Total Day Supply
39,611
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$253K
Generic Drug Cost
$92K
Antibiotic Claims
42

Patient Demographics

Average Patient Age
67.5 years
Avg HCC Risk Score
2.51
Gender Split
52% female / 48% male
Age Distribution
<65: 38, 65-74: 91, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MING LIN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Tacrolimus
147
Ursodiol
108
Omeprazole
41
Azathioprine
37
Vemlidy
Tenofovir Alafenamide
37
Mycophenolate Mofetil
32
Entecavir
31
Spironolactone
29
Xifaxan
Rifaximin
28
Furosemide
25

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Transplant Hepatology Physician Overview

How MING LIN, MD fits within the Transplant Hepatology Physician landscape nationally.

131
Transplant Hepatology Physician Providers in US
36
States with Transplant Hepatology Physician
536
Avg Claims per Provider

MING LIN, MD's 671 claims are above the specialty average of 536.

Nearby Transplant Hepatology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as LIN.

Compare Transplant Hepatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MING LIN, MD's specialty?
MING LIN, MD specializes in Transplant Hepatology Physician and practices in BURLINGTON, Massachusetts. Credentials: MD.
How much does MING LIN, MD prescribe under Medicare Part D?
In 2023, MING LIN, MD wrote 671 Medicare Part D claims totaling $346K in drug costs for 159 beneficiaries.
Where is MING LIN, MD located?
MING LIN, MD is located at LAHEY HOSPITAL & MEDICAL CENTER, BURLINGTON, MA, 01805. Phone: (781) 744-2500.
What is MING LIN, MD's NPI number?
MING LIN, MD's National Provider Identifier (NPI) is 1043404593, issued on 08/28/2007.
Does MING LIN, MD prescribe more brand-name or generic drugs?
MING LIN, MD's prescribing is 15% brand-name and 85% generic drugs by claim count, with $253K in brand drug costs.
How many Transplant Hepatology Physician providers are there in the US?
There are 131 Transplant Hepatology Physician providers across 36 states in the US. The average Transplant Hepatology Physician provider writes 536 Medicare Part D claims per year.
What drugs does MING LIN, MD prescribe most often?
Based on 2023 Medicare Part D data, MING LIN, MD's most frequently prescribed drugs include Tacrolimus, Ursodiol, Omeprazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MING LIN, MD accept Medicare?
MING LIN, MD appears in CMS Medicare data with 671 Part D claims and 159 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MING LIN, MD's credentials?
MING LIN, MD's NPI is 1043404593 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology